Understanding and treating a specific type of acute leukemia caused by NUP98 gene changes
Official title: Experimental and preclinical modeling of NUP98-rearranged acute leukemia
Funded at St. Jude Children's Research Hospital · NIH-10829603 · Data updated 2026-11-12
This study is looking at a tough type of leukemia called NUP98-rearranged acute leukemia to find better ways to understand and treat it, using new techniques to see how certain genetic changes cause the disease and what new treatments might help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | St. Jude Children's Research Hospital NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $161,500 |
| NIH project number | 3U54CA243124-01S3 |
| Project ID | NIH-10829603 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with NUP98-rearranged acute leukemia.
✕Less likely to help
Patients with other types of leukemia or those without NUP98 rearrangements may not benefit from this research.
What this research studies
This research focuses on NUP98-rearranged acute leukemia, a high-risk form of leukemia. The team aims to develop better experimental models to study this disease and identify how specific genetic changes lead to leukemia. By using advanced techniques like cell barcoding and single-cell sequencing, they will explore the biology of the disease and potential new therapies. This work is designed to improve understanding and treatment options for patients with this type of leukemia.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with NUP98-rearranged acute leukemia.
How similar studies have gone: Previous research has shown promise in using similar genetic and modeling approaches to understand and treat various forms of leukemia.
Where this research is happening
-
St. Jude Children's Research Hospital
Memphis, United States Active
Researchers
- Principal investigator: Mullighan, Charles G. — St. Jude Children's Research Hospital
- Study coordinator: Mullighan, Charles G.
Related research
Other NIH-funded projects on the same topics.
-
Investigating a specific type of leukemia in children caused by genetic changes.
This study is looking at how certain proteins linked to leukemia affect kids and teens with high-risk blood cancers, and the researchers hope to find new ways to treat these conditions by learning more about how the disease works.
-
Reducing leukemia disparities in Latino children and teens
A large, multi-project effort aims to understand why Latino children with acute lymphoblastic leukemia have worse outcomes and how to reduce those gaps.
-
Genomic advances to improve outcomes in high-risk acute leukemia
A physician-scientist team is studying the genetic drivers of pediatric acute leukemia to find new ways to diagnose and treat it, with the goal of improving cure rates for kids.
-
Understanding and Targeting Extramedullary Acute Leukemia
A clinician-research team is studying myeloid sarcoma, a form of AML that forms solid tumors outside the bone marrow, to develop new treatments for patients.
-
Diversifying acute leukemia trial enrollment through multilevel approach
Aiming to broaden participation in acute leukemia trials by testing a multi-layer plan that addresses barriers for adults with AML.
-
Blocking menin to treat acute leukemias with high HOX gene activity
This work develops new drugs that block a protein called menin to help people with certain aggressive acute leukemias driven by HOX gene activation.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.